n

%

Age median (range)

39

(16 - 65)

Sex

Male/female

11/8

Diagnosis

AML

6

31.6

ALL

3

15.8

MDS

3

15.8

CML

1

5.3

AA

1

5.3

ML

5

26.3

Stem cell source

PBSC

5

26.3

BM

7

36.8

CB

7

36.8

Conditioning regimen

MAC

11

57.9

RIC

8

42.1

GVHD prophylaxis

CsA + MTX

9

47.4

TAC + MTX

10

52.6

GI stage of acute GVHD at colonoscopy (n = 32)

0

12

37.5

1

13

40.6

2

1

3.1

3

3

9.4

4

3

9.4